+
Almeida
HL, Kopp
J, Jorge
VM,
et al. Extensive hydroa vacciniforme. An Bras Dermatol 2013; 88(4):620–2.
+
Doeden
K, Molina-Kirsch
H, Perez
E,
et al. Hydroa-like lymphoma with CD56 expression. J Cutan Pathol 2008; 35(5):488–94.
+
Fujiwara
S, Kimura
H, Imadome
K,
et al. Current research on chronic active Epstein-Barr virus infection in Japan. Pediatr Int 2014; 56(2):159–66.
+
Haddad
J M, Monroe
HR, Hardin
J,
et al. Hydroa vacciniforme: a rare photodermatosis. Dermatol Online J 2014; 20(8).
+
Hamada
T, Nakamura
S, Ko
YH,
et al. Epstein-Barr virus-associated T/natural killer-cell lymphomas in the elderly: the first consensus meeting in Kofu 2013. J Dermatol 2014; 41(1):40–2.
+
Ibarra-Durán
G, Rodríguez-Jurado
R, Rodríguez-Moguel
L, Valencia-Mayoral
P. Linfoma T cutáneo angiocéntrico en una niña con hidroa vacuniforme. Dermatología Rev Mex 1991; 35(5):344–8.
+
Iwatsuki
K, Satoh
M, Yamamoto
T,
et al. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus associated hematologic disorders. Arch Dermatol 2006; 142(5):587–95.
+
Lysell
J, Wiegleb Edstrom
D, Linde
A,
et al. Antiviral therapy in children with hydroa vacciniforme. Acta Derm Venereol 2009; 89(4):393–7.
+
Mendoza
N, Diamantis
M, Arora
A,
et al. Mucocutaneous manifestations of Epstein-Barr virus infection. Am J Clin Dermatol 2008; 9(5):295–305.
+
Nishizawa
A, Satoh
T, Takayama
K, Yokozaki
H. Hydroa vacciniforme with mucosal involvement and recalcitrant periodontitis and multiple virus re-activators after sunexposure. Acta Derm Venereol 2010; 90(5):498–501.
+
Oono
T, Arata
J, Masuda
T. Coexistence of hydroa vacciniforme and malignant lymphoma. Arch Dermatol 1986; 122:1306.
+
Park
HY, Park
JH, Lee
KT,
et al. A case of hydroa vacciniforme. Ann Dermatol 2010; 22(3):312–5.
+
Rodríguez-Pinilla
SM, Barrionuevo
C, García
J,
et al. EBV associated cutaneous NK/T-cell lymphoma: review of a series of 14 cases from Peru in children and young adults. Am J Surg Pathol 2010; 34(12):1773–82.
+
Ruiz-Maldonado
R, Millán-Parrilla
F, Orozco-Covarrubias
ML,
et al. Edematous, scarring vasculitic panniculitis: a new multisystemic disease with malignant potential. J Am Acad Dermatol 1995; 32:37–44.
+
Shi
J Q, Chen
QX, Li
SF, Li
W. Hydroa vacciniforme-like cutaneous T-cell lymphoma. Indian J Dermatol 2014; 59(1):91–3.
+
Takeuchi
T, Kamide
R. Severe hydroa vacciniforme-like eruptions confined to sun-exposed areas. J Dermatol 2011; 38(4):386–9.
+
Verneuil
L, Gouarin
S, Comoz
F,
et al. Epstein-Barr virus involvement in the pathogenesis of hydroa vacciniforme: an assessment of seven adult patients with long-term followup. Br J Dermatol 2010; 163(1):174–82.
+
Yang
YQ, Fan
L, Wang
L,
et al. Systemic lymphoma arising from hydroa vacciniforme-like lymphoma: report of two cases with review of literature. Int J Clin Exp Pathol 2014; 7(9):6403–8.
+
Wu
YH, Chen
HC, Hsiao
PF,
et al. Hydroa vacciniforme like Epstein-Barr virus-associated monoclonal T-lymphoproliferative disorder in a child. Int J Dermatol 2007; 46(10):1081–6.
+
Xie
JL, Chen
GY, Jin
Y,
et al. Hydroa vacciniforme present for 48 years with cytotoxic CD4+ T cell infiltration and Epstein-Barr virus infection. Br J Dermatol 2012; 166(2):449–51.
+
Xu
Z, Lian
S. Epstein-Barr virus-associated hydroa vacciniforme-like cutaneous lymphoma in seven Chinese children. Pediatr Dermatol 2010; 27(5):463–9.